15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Xponential Fitness Inc, 0 rate it Buy or better, 8 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $5.00 to $5.00, so the covering firms are broadly aligned. The average target of $5.00 sits 4% above the current $4.80. The rating mix has stayed broadly stable, with Buy-side ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.18 next quarter toward $0.66 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Hold
Strong Buy00%
Buy00%
Hold8100%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to Xponential Fitness Inc.
As of Sep, 0 of 8 firms rate XPOF a Buy (8 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
XPOF EPS & revenue forecast
EPS · NEXT QUARTER
$0.18
Range $0.16 – $0.20 · 3 analysts · -120% YoY
Next period, 3 analysts expect Xponential Fitness Inc to earn $0.18 a share (range $0.16 – $0.20), versus $-0.91 a year earlier. Full-year consensus is $0.29, growing to $0.66 the year after.
REVENUE · NEXT QUARTER
$66.5M
Range $60.7M – $72.5M · 3 analysts · -20% YoY
Revenue is expected to reach $66.5M (range $60.7M – $72.5M), -19.8% year-over-year. Full-year consensus is $256.6M, rising to $271.2M next year.
Top analysts covering Xponential Fitness Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XPOF.
#1
Jeff Van Sinderen
B. Riley Securities · Rank #81
Hold
$5.00+4.2% to target
Overall win rate
44%
+ Follow
#2
George Kelly
Roth MKM · Rank #226
Hold
$5.00+4.2% to target
Overall win rate
43%
+ Follow
#3
NZ
Noah Zatzkin
Keybanc
Hold
No targeton XPOF
Coverage
—
+ Follow
#4
John Heinbockel
Guggenheim
Hold
No targeton XPOF
Coverage
—
+ Follow
#5
Joseph Altobello
Raymond James
Hold
No targeton XPOF
Coverage
—
+ Follow
XPOF stock forecast FAQ
What is XPOF's average 12-month price target?+
The 2 analysts with a live target average $5.00 for Xponential Fitness Inc over the next 12 months, ranging from a $5.00 high to a $5.00 low.
Is XPOF stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 8 analyst ratings, 0 are Buy or Strong Buy, 8 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover XPOF?+
8 analysts have an active rating on Xponential Fitness Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering XPOF?+
Among analysts who currently cover XPOF, Jeff Van Sinderen of B. Riley Securities has the strongest overall Quantellect track record (Rank #81). Their current call is Hold with a $5.00 target.
What is Xponential Fitness Inc's projected EPS for next quarter?+
The consensus estimate is $0.18 per share (range $0.16 – $0.20) across 3 analysts. Full-year EPS is projected at $0.29, rising to $0.66 the following year.
How much revenue is Xponential Fitness Inc expected to report next quarter?+
Consensus revenue is $66.5M (range $60.7M – $72.5M). Full-year revenue is projected at $256.6M, growing to $271.2M next year.
Have analysts been upgrading or downgrading XPOF lately?+
As of Sep, 0 of 8 firms rate XPOF a Buy (8 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XPOF calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
